(Q29401673)

14 April 2017

title

REM sleep and cortisol response to the cholinergic challenge with RS 86 in normals and depressives (English)

1 reference

14 April 2017

0 references

0 references

Krieg JC

1

1 reference

14 April 2017

Berger M

series ordinal

2

1 reference

14 April 2017

language of work or name

English

0 references

publication date

1 November 1987

1 reference

Acta Psychiatrica Scandinavica

14 April 2017

published in

1 reference

14 April 2017

volume

76

1 reference

14 April 2017

issue

5

1 reference

14 April 2017

page(s)

600-602

1 reference

A cholinergic-adrenergic hypothesis of mania and depression

14 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1987.TB02926.X

Diagnostic Criteria for Use in Psychiatric Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1987.TB02926.X

REM Sleep Induction by Physostigmine Infusion During Sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1987.TB02926.X

Effects of RS 86, an orally active cholinergic agonist, on sleep in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1987.TB02926.X

Central muscarinic effects of physostigmine on mood, cardiovascular function, pituitary and adrenal neuroendocrine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1987.TB02926.X

Cholinergic regulation of mood and REM sleep: potential model and marker of vulnerability to affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1987.TB02926.X

10.1111/J.1600-0447.1987.TB02926.X

21 January 2018

Identifiers

DOI

1 reference

14 April 2017

1 reference